Sleep EEG effects of anti-gluco- and anti-mineralocorticoids in old-aged men: Pilot study

4Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Aim Age-related sleep changes have been associated with altered hypothalamic-pituitary-adrenal axis reactivity and impaired feedback inhibition at the glucocorticoid (GR) and mineralocorticoid (MR) receptor level. To further investigate the specific role of this binary receptor system in the elderly, sleep electroencephalogram (EEG) effects of the MR antagonist spironolactone and GR antagonist mifepristone in old-aged men were compared in this pilot study. Methods Old-aged healthy men (n = 6, 65-91 years) were treated on three occasions in a single-blinded design in random order with mifepristone, spironolactone and placebo, respectively, and nocturnal sleep EEG was recorded. Results Mifepristone led to increased wake time, decreased stage 2 and rapid eye movement (REM) sleep and prolonged REM sleep latency in the first half of the night, whereas spironolactone had no considerable effects on sleep EEG. Conclusion GR antagonism can potentiate age-related sleep pattern alterations and further support the role of impaired GR signaling in age-related changes in sleep architecture. © 2014 The Authors. Psychiatry and Clinical Neurosciences © 2014 Japanese Society of Psychiatry and Neurology.

Cite

CITATION STYLE

APA

Demiralay, C., Agorastos, A., Steiger, A., & Wiedemann, K. (2014). Sleep EEG effects of anti-gluco- and anti-mineralocorticoids in old-aged men: Pilot study. Psychiatry and Clinical Neurosciences, 68(5), 383–387. https://doi.org/10.1111/pcn.12142

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free